Prolonged Survival of a 79-Year Old Man with Acute Myeloid Leukemia M2, Normal Karyotype, NPM1 and FLT3-ITD Mutations, WBC 33.7 × 109/L, and Involving only Granulocyte-Macrophage Line on 53 Cycles of Low-Dose Cytarabine